ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Beyond Air (XAIR)
Beyond Air stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · NASDAQ
$2.21▲ +3.27%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
45%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Beyond Air in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Beyond Air
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Beyond Air a 45% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $1.84 and $2.51; in 9 out of 10, between $1.40 and $3.30. Estimated annual volatility is 90%.
Key numbers
- Revenue (12 months)
- $7.7M
- Revenue growth (YoY)
- +107.3%
- Gross margin
- 3.3%
- Operating margin
- -378.2%
- Net margin
- -447.1%
- Free cash flow (12 months)
- $-14.1M
- Beta
- 0.13
What this means
ATLAS does not publish a fair value for XAIR right now, but it does show its odds of rising: close to a coin flip.
On the business: revenue grew 107.3% year over year; net margin is 447.1%.
Its beta is 0.13: it tends to move less than the market.
About the company
Beyond Air Inc. is a commercial-stage medical device and biopharmaceutical company focused on nitric oxide-based therapies and delivery systems.
Want to see everything about Beyond Air?
Get started →Plans from €3.99 a month.
Frequently asked questions
What does Beyond Air do?
Beyond Air Inc. is a commercial-stage medical device and biopharmaceutical company focused on nitric oxide-based therapies and delivery systems.
What is the chance XAIR goes up next month?
45%: close to a coin flip. In half of the simulated outcomes, XAIR ends the month between $1.84 and $2.51.
How volatile is XAIR?
ATLAS estimates annual volatility at 90%. In a typical month, half of the outcomes end between $1.84 and $2.51.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer